Hyperkalemic periodic paralysis.

The research focuses on a genetic condition known as Hyperkalemic Periodic Paralysis in horses, which is traced back to a breed known as the quarter horse sire Impressive. The condition presents certain muscular traits which have inadvertently been favored during selection processes, resulting in a wider spread of the disease. The symptoms which include muscle spasms are managed through treatments targeting a related condition, hyperkalemia.

Background of the Research

• The research centers around a hereditary horse disease referred to as ‘Hyperkalemic Periodic Paralysis’, or HYPP. The condition is prevalent in horses with lineage traced back to the quarter horse sire named Impressive.
• The condition is classified as an ‘autosomal codominant’ disease, which means that a single copy of the gene can cause the disease, even if the accompanying gene is normal.

The Disease and its Impact

• HYPP causes a certain muscular form or ‘phenotype’ that has been inadvertently selected by horse show judges due to its appeal. As a result, the disease has disseminated extensively among certain horse populations.
• Physical manifestations of HYPP are characterized by muscle fasciculation, which refers to involuntary muscle contractions, and spasms.

Treatment of the Disease

• The research highlights that the symptomatic attacks in the horses are responsive to treatments designed for a simultaneous condition known as hyperkalemia – a situation that involves excessive potassium in the blood.
• By managing hyperkalemia, the symptoms of HYPP can be mitigated, providing alleviation to the affected horses.

Significance of the Research

• This research provides valuable insight into the propagation of HYPP among horses and its relationship with selective breeding practices. It underscores the need for careful genetic screening during breed selection.
• It also presents a treatment pathway for managing the disease by highlighting the responsiveness of HYPP symptoms to hyperkalemia treatments.